These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


151 related items for PubMed ID: 15566088

  • 1. Effect of glomerular filtration rate on clearance and myelotoxicity of carboplatin in cats with tumors.
    Bailey DB, Rassnick KM, Erb HN, Dykes NL, Hoopes PJ, Page RL.
    Am J Vet Res; 2004 Nov; 65(11):1502-7. PubMed ID: 15566088
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of serum iohexol clearance for use in predicting carboplatin clearance in cats.
    Bailey DB, Rassnick KM, Prey JD, Dykes NL.
    Am J Vet Res; 2009 Sep; 70(9):1135-40. PubMed ID: 19719430
    [Abstract] [Full Text] [Related]

  • 3. Phase I evaluation of carboplatin by use of a dosing strategy based on a targeted area under the platinum concentration-versus-time curve and individual glomerular filtration rate in cats with tumors.
    Bailey DB, Rassnick KM, Dykes NL, Pendyala L.
    Am J Vet Res; 2009 Jun; 70(6):770-6. PubMed ID: 19496668
    [Abstract] [Full Text] [Related]

  • 4. Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer Institute.
    Millward MJ, Webster LK, Toner GC, Bishop JF, Rischin D, Stokes KH, Johnston VK, Hicks R.
    Aust N Z J Med; 1996 Jun; 26(3):372-9. PubMed ID: 8811211
    [Abstract] [Full Text] [Related]

  • 5. Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing.
    Donahue A, McCune JS, Faucette S, Gillenwater HH, Kowalski RJ, Socinski MA, Lindley C.
    Cancer Chemother Pharmacol; 2001 May; 47(5):373-9. PubMed ID: 11391850
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical pharmacokinetics and dose optimisation of carboplatin.
    Duffull SB, Robinson BA.
    Clin Pharmacokinet; 1997 Sep; 33(3):161-83. PubMed ID: 9314610
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae.
    Okamoto H, Nagatomo A, Kunitoh H, Kunikane H, Watanabe K.
    Cancer Chemother Pharmacol; 1998 Sep; 42(4):307-12. PubMed ID: 9744776
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tikhonov gamma variate adaptive regularization applied to technetium Tc 99m diethylenetriamine pentaacetic acid plasma clearance, compared with three other methods, for measuring glomerular filtration rate in cats.
    Snead EC, Milo JE, McCrea CA, Montgomery JE, Feng CX, Wesolowski MJ, Wanasundara SN, Wesolowski CA.
    Am J Vet Res; 2019 Apr; 80(4):416-424. PubMed ID: 30919678
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
    Calvert AH, Newell DR, Gumbrell LA, O'Reilly S, Burnell M, Boxall FE, Siddik ZH, Judson IR, Gore ME, Wiltshaw E.
    J Clin Oncol; 2023 Oct 01; 41(28):4453-4454. PubMed ID: 37757592
    [Abstract] [Full Text] [Related]

  • 18. Hematologic and systemic toxicoses associated with carboplatin administration in cats.
    Hahn KA, McEntee MF, Daniel GB, Legendre AM, Nolan ML.
    Am J Vet Res; 1997 Jun 01; 58(6):677-9. PubMed ID: 9185979
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.